NCT05291260

Brief Summary

A complete rupture of the ulnar collateral ligament (UCL) of the thumb must heal in order to regain proper function of the thumb. Guidelines recommend surgery for complete UCL ruptures, including Stener lesions. This recommendation is based on expert opinion, anatomic theories and low quality retrospective case series. High quality studies comparing cast immobilization with operative treatment are lacking. Research has shown that in about 9 out of 10 patients, a complete UCL rupture, including Stener Lesions, can also be treated with a cast alone for 6 weeks and no surgery is needed. We hypothesize that cast immobilization is non-inferior regarding functional outcome and carries concomitant lower costs compared with operative treatment for complete UCL ruptures, including Stener Lesions. The project aims to conduct a multicenter randomized controlled trial and cost-effectiveness analysis comparing operative and nonoperative treatment for complete UCL ruptures, including Stener Lesions. The project will take four years, from preparation to reporting of the results. In the following years, implementation will be achieved in collaboration with the Dutch hand surgery committees (NVvH and NVPC), health insurance companies, and medical experts. Research question Is nonoperative treatment with splint immobilization non-inferior to immediate operative treatment regarding functional outcome and does it lead to lower costs in adult patients with an acute complete UCL rupture, including Stener Lesions?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Feb 2022Jul 2026

Study Start

First participant enrolled

February 17, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 22, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

August 21, 2025

Status Verified

September 1, 2024

Enrollment Period

3.6 years

First QC Date

March 3, 2022

Last Update Submit

August 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Michigan Hand outcome Questionnaire (MHQ)

    The MHQ, expressed as the MHQ at 6 months (from randomization to 6 months after) is the primary endpoint of the study. The MHQ is a validated tool for assessment of functional outcome in patients with pathology of the hand. The MHQ is a questionnaire divided in six subscales; overall hand function, activities of daily living (ADLs), pain, work performance, aesthetics and patient satisfaction with hand function. Each subscale has a formula to calculate a score. The final score is a summation of the six individual item-scores divided by six and goes from 0 (severe disability) to 100 (no disability).

    6 months

Secondary Outcomes (12)

  • Patient-Specific Functional Scale (PSFS)

    at randomization, 2, 3, 6 and 12 months after randomization.

  • EQ-5D-5L

    at randomization, 2, 3, 6 and 12 months after randomization.

  • Michigan Hand outcome Questionnaire (MHQ)

    at randomization, 2, 3 and 12 months after randomization.

  • The Numeric Pain Rating Scale (NPRS)

    at randomization, 2, 3, 6 and 12 months after randomization.

  • Patient satisfaction

    at randomization, 2, 3, 6 and 12 months after randomization.

  • +7 more secondary outcomes

Study Arms (2)

Cast immobilization

EXPERIMENTAL

Cast immobilization to immobilize the thumb for 4 weeks. After 2 weeks the thumb will be re-examined to determine if surgery is required. It is expected that at re-evaluation at 2 weeks after starting the cast treatment about 1 in 10 patients will still need surgery.

Procedure: Cast immobilization

Surgery

ACTIVE COMPARATOR

The intervention is compared to surgery, which is standard treatment for complete ulnar collateral ligament ruptures.

Procedure: Surgical treatment

Interventions

A cast to immobilize the MCP, in 10-30 degrees (slight) flexion (neutral position), and the CMC joint, in 30-40 degrees palmar abduction, is applied (IP joint is free).

Cast immobilization

In general, two surgical techniques are described in literature and used in daily clinical practice: * If the UCL is ruptured in the middle of the ligament, sutures are used to reattach the ligament remnants together. * When no viable UCL ligaments are present, the UCL is reattached directly to the bone using suture anchors.

Surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years and older
  • Dutch or English speaking patients
  • Patients with an acute complete UCL rupture, with or without a Stener Lesion, diagnosed using physical examination, performed by the hand surgeon. When providing radically directed force to the proximal phalanx (radial deviation stress) as the thumb metacarpal is stabilized, criteria 1 AND 2 must be present to confirm the diagnosis of a complete UCL rupture:
  • no firm endpoint in the MCP joint AND
  • at least more than 35 degrees of laxity in the MCP joint (measured with the MCP joint in extension or in 30 degrees of flexion) OR more than 15 degrees difference in laxity compared with the uninjured side.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diakonessenhuis Utrecht

Utrecht, Utrecht, 3582KE, Netherlands

Location

Related Publications (6)

  • Pulos N, Shin AY. Treatment of Ulnar Collateral Ligament Injuries of the Thumb: A Critical Analysis Review. JBJS Rev. 2017 Feb 21;5(2):e3. doi: 10.2106/JBJS.RVW.16.00051. No abstract available.

    PMID: 28248741BACKGROUND
  • Pichora DR, McMurtry RY, Bell MJ. Gamekeepers thumb: a prospective study of functional bracing. J Hand Surg Am. 1989 May;14(3):567-73. doi: 10.1016/s0363-5023(89)80026-7.

    PMID: 2738347BACKGROUND
  • Landsman JC, Seitz WH Jr, Froimson AI, Leb RB, Bachner EJ. Splint immobilization of gamekeeper's thumb. Orthopedics. 1995 Dec;18(12):1161-5. doi: 10.3928/0147-7447-19951201-06.

    PMID: 8749294BACKGROUND
  • Samora JB, Harris JD, Griesser MJ, Ruff ME, Awan HM. Outcomes after injury to the thumb ulnar collateral ligament--a systematic review. Clin J Sport Med. 2013 Jul;23(4):247-54. doi: 10.1097/JSM.0b013e318289c6ff.

    PMID: 23615487BACKGROUND
  • Mikhail M, Wormald JCR, Thurley N, Riley N, Dean BJF. Therapeutic interventions for acute complete ruptures of the ulnar collateral ligament of the thumb: a systematic review. F1000Res. 2018 Jun 8;7:714. doi: 10.12688/f1000research.15065.1. eCollection 2018.

    PMID: 30057756BACKGROUND
  • de Haas L, van Hoorn B, van de Lucht V, Schep N, Dijkgraaf M, van Heijl M; MUSCAT Trial Collaborator group. Study protocol for a multicenter non-inferiority randomized controlled trial to assess functional outcomes and cost-effectiveness of a primarily non-operative treatment strategy with cast immobilization versus immediate operative treatment followed by cast immobilization for patients with complete ulnar collateral ligament ruptures, including Stener lesions: MUSCAT study. Trials. 2024 Oct 28;25(1):723. doi: 10.1186/s13063-024-08576-x.

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Officials

  • Mark van Heijl, MD, PhD

    Diakonessenhuis, Utrecht

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Not possible for surgical intervention vs cast immobilization
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2022

First Posted

March 22, 2022

Study Start

February 17, 2022

Primary Completion

October 1, 2025

Study Completion (Estimated)

July 31, 2026

Last Updated

August 21, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

An official Data Management Plan has been developed, in accordance with the official format used in the Netherlands.

Shared Documents
STUDY PROTOCOL
Time Frame
When the manuscripts are published
More information

Locations